Navigation Links
Further Studies on AIDS Prevention Gels Stopped

Researchers have discontinued further studies on anti-AIDS vaginal gel in Africa and India, following results of recent trials, which indicated// that it could enhance the risk of HIV infection, instead of reducing it.

The gel in question, called Ushercell, contains a cotton-based compound called cellulose sulfate. This gel is developed by Polydex Pharmaceuticals, a company in Toronto.

More than 50% of AIDS infections in Africa concern women and girls. Researchers have been contemplating the employment of other protective measures which could be used by women, even without the knowledge of their partners. Scientists thought this would help in the scenario of many men refusing to use any protection during sex.

A study with 1,500 women in South Africa, Benin, Uganda, and India had to be halted during this week after a supervising board observed an increase in HIV infections among women using the gel, in contrast to women who were given an inactive medication.

"I cannot think of any biological basis for these findings, and I hope that further analysis of all of the data may shed further light on this important question," said USAID's research chief, Jeff Spieler.

"We did not find any evidence of greater risk of HIV infection," said a statement from Dr. Vera Halpern, who had spearheaded the Nigeria study. "But we also found no evidence that the product was effective."

Almost eleven trials had been conducted in The United States to evaluate the effectiveness of this gel, which had found the product to be safe and effective.
'"/>




Page: 1

Related medicine news :

1. Further support for use of statins in Alzheimer’s disease
2. Clinical Impact of Activity and Abdominal Pressure on Pelvic Floor Dysfunction Need to Be Further Analyzed
3. Doctor Accused Of Misdiagnosing 208 Patients: Further Investigation Ordered
4. NHS Recommends Further Cost Cutting Measures
5. Medha Patkars Condition Deteriorates Further
6. Oxford Radcliffe Hospitals Warns Of Further Job Losses
7. Further Studies Needed To Completely Understand About Ventricular Fibrillation
8. Further improvements envisaged at Carstairs
9. UCLA Find Yields Further Insight into Causes of Parkinson’s Diseas
10. Salt Consumption Needs To Drop Further
11. Studies On Hearing Loss Discovers New Causes
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance ... and the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, ... Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood cells, ...
(Date:6/24/2016)... ... 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida ... their peers for this recognition are considered among the top 2 percent of lawyers ... as members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, ... minimum wage raise to $12 an hour by 2020 and then adjusting it yearly to ... value of the minimum wage, assure the wage floor does not erode again, and make ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty Network, affiliated ... Weintraub as a prominent plastic surgeon and the network’s newest partner. , ... most handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm Slone ... executive with extensive sequencing and genomics experience, as Vice President of North American Capital ... will be responsible for leading the sales team in the commercialization of the HTG ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... --  Pulmatrix, Inc ., (NASDAQ: PULM ), ... today that it was added to the Russell Microcap ... set of U.S. and global equity indexes on June ... for Pulmatrix," said Chief Executive Officer Robert Clarke ... in developing drugs for crucial unmet medical needs, and ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
Breaking Medicine Technology: